NL7512541A - NEW PHARMACEUTICALLY ACTIVE AZACYCLICAL COMPOUNDS AND THERAPEUTICALLY ACCEPTABLE SALTS THEREOF, METHODS FOR PREPARING THEM AND PREPARATIONS FOR CONTROLLING FAT TREASURE CONTAINING THESE COMPOUNDS AND SALTS. - Google Patents

NEW PHARMACEUTICALLY ACTIVE AZACYCLICAL COMPOUNDS AND THERAPEUTICALLY ACCEPTABLE SALTS THEREOF, METHODS FOR PREPARING THEM AND PREPARATIONS FOR CONTROLLING FAT TREASURE CONTAINING THESE COMPOUNDS AND SALTS.

Info

Publication number
NL7512541A
NL7512541A NL7512541A NL7512541A NL7512541A NL 7512541 A NL7512541 A NL 7512541A NL 7512541 A NL7512541 A NL 7512541A NL 7512541 A NL7512541 A NL 7512541A NL 7512541 A NL7512541 A NL 7512541A
Authority
NL
Netherlands
Prior art keywords
compounds
salts
azacyclical
treasure
preparations
Prior art date
Application number
NL7512541A
Other languages
Dutch (nl)
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of NL7512541A publication Critical patent/NL7512541A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NL7512541A 1974-10-30 1975-10-27 NEW PHARMACEUTICALLY ACTIVE AZACYCLICAL COMPOUNDS AND THERAPEUTICALLY ACCEPTABLE SALTS THEREOF, METHODS FOR PREPARING THEM AND PREPARATIONS FOR CONTROLLING FAT TREASURE CONTAINING THESE COMPOUNDS AND SALTS. NL7512541A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51939674A 1974-10-30 1974-10-30

Publications (1)

Publication Number Publication Date
NL7512541A true NL7512541A (en) 1976-05-04

Family

ID=24068150

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7512541A NL7512541A (en) 1974-10-30 1975-10-27 NEW PHARMACEUTICALLY ACTIVE AZACYCLICAL COMPOUNDS AND THERAPEUTICALLY ACCEPTABLE SALTS THEREOF, METHODS FOR PREPARING THEM AND PREPARATIONS FOR CONTROLLING FAT TREASURE CONTAINING THESE COMPOUNDS AND SALTS.

Country Status (14)

Country Link
JP (1) JPS51125273A (en)
AU (1) AU8606075A (en)
BE (1) BE834928A (en)
DE (1) DE2548053A1 (en)
DK (1) DK482775A (en)
FI (1) FI753006A (en)
FR (1) FR2289185A1 (en)
GB (1) GB1517934A (en)
IL (1) IL48369A0 (en)
LU (1) LU73660A1 (en)
NL (1) NL7512541A (en)
NO (1) NO753594L (en)
SE (1) SE7512066L (en)
ZA (1) ZA756740B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4173566A (en) * 1974-10-30 1979-11-06 Schering Corporation 1-Benzhydryl-2-cyanoazetidine
US4133881A (en) * 1977-04-27 1979-01-09 A. H. Robins Company, Incorporated Azetidinyl acetonitrile and acetamide antiarrhythmia compositions and methods
JPS5632454A (en) * 1979-08-24 1981-04-01 Takeda Chem Ind Ltd Azetidine derivative
US5198449A (en) * 1990-04-27 1993-03-30 A. H. Robins Company Incorporated N-substituted alpha-arylazacycloalkylmethanamines and their use as cardiovascular agents
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903827D0 (en) * 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods

Also Published As

Publication number Publication date
FI753006A (en) 1976-05-01
AU8606075A (en) 1977-05-05
ZA756740B (en) 1976-10-27
FR2289185A1 (en) 1976-05-28
SE7512066L (en) 1976-05-03
DK482775A (en) 1976-05-01
IL48369A0 (en) 1975-12-31
JPS51125273A (en) 1976-11-01
NO753594L (en) 1976-05-03
LU73660A1 (en) 1976-08-19
GB1517934A (en) 1978-07-19
BE834928A (en) 1976-04-28
DE2548053A1 (en) 1976-05-06

Similar Documents

Publication Publication Date Title
NL7514811A (en) PROCESS FOR PREPARING NEW THIAZOLYLACET-AMID COMPOUNDS, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS, AND FORMED PHARMACEUTICAL PREPARATIONS.
NL7704057A (en) PROCESS FOR PREPARING NEW CEFOLOSPORIN DERIVATIVES, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND FORMED PHARMACEUTICAL PREPARATIONS.
NL7713817A (en) NEW THERAPEUTICALLY ACTIVE PIPERAZINE DERIVATIVES, METHODS OF PREPARING THE SAME AND PHARMACIC PREPARATIONS CONTAINING THESE COMPOUNDS.
BE859425A (en) FENOXY-AMINO PROPANOLS AND PROCESS FOR THE PREPARATION THEREOF, AND METHODS FOR PREPARING PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS
NL7710502A (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND PROCESS FOR PREPARING NEW ANALGETICALLY ACTIVE COMPOUNDS.
NL7510535A (en) PROCESS FOR THE PREPARATION OF NEW ARYLPIPERIINES, AND PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS.
NL7611972A (en) PROCESS FOR PREPARING NEW BENZOTHIOPHENE DERIVATIVES AND PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS.
NL7601455A (en) PROCESS FOR PREPARING PROSTAGLANDIN ANALOGA; PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND FORMED PRODUCTS.
NL7612794A (en) AMINOALCOHOL DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND METHODS FOR PREPARING THEM.
NL7611295A (en) PROCESS FOR PREPARING NEW GALENIC PREPARATIONS.
NL7611528A (en) NEW SUBSTITUTED 4-AMINOPYRAZOLES, METHODS FOR PREPARING THEM, AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS.
NL7803623A (en) N-ACETYL-DEHYDRO-THIENAMYCIN AND SALTS THEREOF; PROCESS FOR PREPARING THESE COMPOUNDS AND PHARMACEUTICAL PREPARATIONS.
NL7512541A (en) NEW PHARMACEUTICALLY ACTIVE AZACYCLICAL COMPOUNDS AND THERAPEUTICALLY ACCEPTABLE SALTS THEREOF, METHODS FOR PREPARING THEM AND PREPARATIONS FOR CONTROLLING FAT TREASURE CONTAINING THESE COMPOUNDS AND SALTS.
NL7506587A (en) PROCEDURE FOR PREPARING NEW DECAHYDROISOCHINOLINE DERIVATIVES AND PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS.
NL7803165A (en) NEW 7-AMINOTHIAZOLYLACETAMIDOCEPHALOSPORANIC ACID COMPOUNDS, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS.
NL7506588A (en) PROCESS FOR PREPARING NEW DECAHYDROISOCHINOLINE COMPOUNDS AND PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS.
NL7514177A (en) PROCESS FOR THE PREPARATION OF NEW ERGOLIN DERIVATIVES AND PROCESS FOR THE PREPARATION OF PHARMACECUTICAL PREPARATIONS CONTAINING THESE ERGOLIN DERIVATIVES.
NL7502988A (en) NEW COMPOUNDS, AND METHOD OF PREPARATION THEREOF, AND THERAPEUTIC PREPARATIONS CONTAINING THESE NEW COMPOUNDS.
NL7706742A (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND PROCESS FOR PREPARING NEW CEPHALOSPLRINE DERIVATIVES.
NL7611761A (en) PROCEDURE FOR PREPARING NEW SUBSTITUTED CYCLICAL AMIDES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.
NL7600846A (en) PROCEDURE FOR PREPARING NEW NAPHTHALENE COMPOUNDS, AS WELL AS PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.
NL7514429A (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND PROCESS FOR PREPARING NEW CEFEM COMPOUNDS.
NL7514113A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS, FORMED PHARMACEUTICAL PREPARATIONS, AND THE PROCESS FOR THE PREPARATION OF NEW CEFEM COMPOUNDS.
NL7611760A (en) PROCEDURE FOR PREPARING NEW SUBSTITUTED CYCLICAL AMIDES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.
SE421614B (en) PROCEDURE FOR PREPARING CERTAIN THERAPEUTICALLY ACTIVE 9-OXO-1 PROSTANOLS

Legal Events

Date Code Title Description
BV The patent application has lapsed